Recent Company News

• 12:17 PM ET Aug 28, 2026
  

  Fosun International: ClubMed Lifestyle Group Submits Listing Application to the Hong Kong Stock Exchange

• 11:36 AM ET Aug 28, 2026
  

  Fosun International: ClubMed Lifestyle Group Proposes Hong Kong Listing, Targeting 85 Resorts Globally by 2030

• 11:00 AM ET Aug 28, 2026
  

  Fosun International proposes spin-off, Hong Kong listing of ClubMed Lifestyle (HK$5.41, 0.00)

• 07:03 AM ET Aug 27, 2026
  

  Fosun International Reports 1H2026 Results: Total Revenue RMB86.96 Billion, Net Profit RMB1.72 Billion

• 06:15 AM ET Aug 27, 2026
  

  Fosun International reports H1 net income attributable CNY1.72B vs guidance CNY1.50-1.80B (HK$5.42, 0.00)

• 05:07 AM ET Aug 27, 2026
  

  NMPA gives conditional marketing approval for Fosun Pharma unit's GR1803 for multiple myeloma (HK$16.56, 0.00)

• 06:51 AM ET Aug 25, 2026
  

  StreetAccount Metrics Recap - Shanghai Fosun Pharmaceutical (Group) Co. H1 Earnings (HK$17.31, 0.00)